Centro Atlantico del Medicamento S.A. (Ceamed; S.A.)
发明人:
McNAUGHTON SMITH Grant,McNAUGHTON SMITH Grant,ESTEVEZ BRAUN Ana,ESTEVEZ BRAUN Ana,JIMENEZ ALONSO Sandra,JIMENEZ ALONSO Sandra,GUTIERREZ RAVELO Angel Domingo,GUTIERREZ RAVELO Angel Domingo,FERNANDEZ PE
申请号：
SI201330385
公开号：
SI2877455T1
申请日:
2013.07.23
申请国别(地区):
SI
年份:
2017
代理人:
摘要：
A compound having the formula (I): for use in treating disease a composition comprising said fused quinonic compound of formula (I) and at least one pharmaceutically acceptable carrier as well as a method of modulating a Janus Kinase-Signal Transduction and Activators of Transcription (JAK-STAT) pathway. The activation of a JAK-STAT pathway is associated with several disease states such as immunological and inflammatory diseases, hyperproliferative disorders including cancer, and myeloproliferative diseases.
